Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 22.3%

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 52,600 shares, a growth of 22.3% from the March 15th total of 43,000 shares. Based on an average daily volume of 54,500 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.1% of the company's shares are short sold.

Analyst Ratings Changes

A number of brokerages have weighed in on SOPH. Royal Bank of Canada reiterated an "outperform" rating and issued a $8.00 target price on shares of SOPHiA GENETICS in a report on Wednesday, March 6th. BTIG Research lifted their price objective on shares of SOPHiA GENETICS from $7.00 to $8.00 and gave the company a "buy" rating in a research note on Wednesday, March 6th.

SOPHiA GENETICS Price Performance

Shares of SOPH remained flat at $5.00 during trading hours on Friday. The stock had a trading volume of 58,796 shares, compared to its average volume of 77,590. SOPHiA GENETICS has a 12 month low of $2.13 and a 12 month high of $7.37. The firm has a market cap of $326.16 million, a price-to-earnings ratio of -4.10 and a beta of 1.17. The business's fifty day moving average is $4.84 and its 200 day moving average is $4.30.

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last announced its quarterly earnings data on Tuesday, March 5th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by ($0.12). SOPHiA GENETICS had a negative net margin of 126.63% and a negative return on equity of 47.40%. The firm had revenue of $17.05 million during the quarter, compared to analyst estimates of $16.78 million. During the same period last year, the business posted ($0.22) EPS. On average, research analysts forecast that SOPHiA GENETICS will post -1.06 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SOPH. Banque Pictet & Cie SA raised its position in SOPHiA GENETICS by 2.3% in the 3rd quarter. Banque Pictet & Cie SA now owns 2,237,340 shares of the company's stock valued at $5,705,000 after buying an additional 50,000 shares during the last quarter. Credit Suisse AG raised its holdings in shares of SOPHiA GENETICS by 5.7% in the fourth quarter. Credit Suisse AG now owns 1,954,620 shares of the company's stock valued at $4,027,000 after purchasing an additional 105,097 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of SOPHiA GENETICS by 12.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,027,562 shares of the company's stock valued at $5,107,000 after purchasing an additional 112,296 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of SOPHiA GENETICS by 2.6% during the fourth quarter. Principal Financial Group Inc. now owns 995,500 shares of the company's stock valued at $4,689,000 after purchasing an additional 24,837 shares in the last quarter. Finally, Millennium Management LLC boosted its holdings in SOPHiA GENETICS by 4.3% during the fourth quarter. Millennium Management LLC now owns 264,533 shares of the company's stock worth $545,000 after purchasing an additional 10,876 shares during the last quarter. Institutional investors and hedge funds own 31.59% of the company's stock.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.